Capricor Therapeutics (CAPR) Long-Term Debt Issuances (2013 - 2018)

Capricor Therapeutics' Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at -$139140.0 for Q2 2018.

• On a quarterly basis, Long-Term Debt Issuances fell 155.66% year-over-year to -$139140.0 in Q2 2018; TTM through Sep 2019 was -$139140.0, a 155.66% decrease from a year earlier, with the FY2020 full-year figure at $318160.0, changed N/A from the prior year.
• Long-Term Debt Issuances declined to -$139140.0 in Q2 2018 per CAPR's latest filing, from $139140.0 in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $2.0 million in Q2 2016 and bottomed at -$139140.0 in Q2 2018.
• The 4-year median for Long-Term Debt Issuances is $250000.0 (2017), against an average of $576417.7.
• Across the five-year window, Long-Term Debt Issuances plunged 83.24% in 2014 and plunged 155.66% in 2018, its largest moves.
• Year by year, Long-Term Debt Issuances stood at -$6667.0 in 2014, then surged by 26348.69% to $1.8 million in 2016, then plunged by 85.71% to $250000.0 in 2017, then plunged by 155.66% to -$139140.0 in 2018.
• Per Business Quant, the three latest CAPR Long-Term Debt Issuances figures stand at -$139140.0 (Q2 2018), $139140.0 (Q1 2018), and $250000.0 (Q4 2017).